Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

Yet, I assess that Viking Therapeutics’s main growth vector will likely be imputed to its ability to commercialize and ...

and only fully powered randomised controlled trial of a multicomponent non-pharmacological intervention targeting sleep disturbance in people living at home with dementia to date. The study will ...

However, early work on stent-like tubular braided structure led to a more sophisticated construct that then later was coined as a flow diverter (FD) and found its way into clinical application ...

Material and methods We conducted a double-blind randomised clinical trial stratified by risk factors ... for treatment of chlorhexidine 0.12% or placebo. Figure 1 shows the flow diagram of ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

Nearly half of sequencing data labeled as endometriosis lacks true disease representation, highlighting the urgent need for more diverse and accurate tissue sampling to advance research in this ...

The ethics committee of Mazandaran University of Medical Sciences, Sari, Iran, approved this study. The study was designed as a randomized, clinical trial (IRCT: 201407256803N8). The inclusion ...

IQVIA (IQV), a global leader in clinical research and healthcare intelligence, has entered into a strategic collaboration with SCRI Development Innovations, the contract ...

OXURION - Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical stage biotechnology company dedicated to pioneering innovative cancer and ...

Q1 2025 Earnings Call Transcript May 11, 2025 Operator: Greetings, and welcome to KORU Medical Systems First Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this ...